Omnicell, Inc. (OMCL) vs Phibro Animal Health Corporation (PAHC)
A side-by-side comparison of Omnicell, Inc. and Phibro Animal Health Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
OMCL
Omnicell, Inc.
$35.18HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
PAHC
Phibro Animal Health Corporation
$37.01HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT
Total return — OMCL vs PAHC
growth of $100 · dividends reinvested · last 10yOMCL -7.5% (-0.8%/yr)PAHC +72.4% (+5.6%/yr)PAHC compounded faster over this window
OMCL PAHC
OMCL vs PAHC: by the numbers
- •OMCL is the larger company ($1.60B vs $1.50B market cap).
- •PAHC trades at the lower trailing earnings multiple (15.17 vs 41.64 P/E), one valuation lens rather than an overall verdict.
- •PAHC converts more revenue to profit (6.57% vs 3.13% net margin).
- •PAHC grew revenue faster over the past five years (12.75% vs 4.77% CAGR).
- •PAHC pays a dividend (1.29% yield), while OMCL has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | OMCL | PAHC |
|---|---|---|
| P/E ratio | 41.64 | 15.17 |
| Forward P/E | 15.51 | 10.57 |
| PEG ratio | N/A | 1.19 |
| P/S ratio | 1.28 | 0.99 |
| P/B ratio | 1.24 | 3.89 |
| EV / EBITDA | 10.66 | 8.91 |
| FCF yield | 8.84% | 0.66% |
Profitability
| Metric | OMCL | PAHC |
|---|---|---|
| Gross margin | 44.77% | 33.71% |
| Operating margin | 4.73% | 13.07% |
| Net margin | 3.13% | 6.57% |
| ROE | 3.03% | 25.87% |
| ROIC | 2.43% | 11.91% |
Dividends
| Metric | OMCL | PAHC |
|---|---|---|
| Dividend yield | N/A | 1.29% |
| Payout ratio | N/A | 19.67% |
Growth (annualized)
| Metric | OMCL | PAHC |
|---|---|---|
| Revenue CAGR (5Y) | 4.77% | 12.75% |
| EPS CAGR (5Y) | -43.29% | 12.92% |
| FCF CAGR (5Y) | -8.10% | -12.27% |
| Total return CAGR (5Y) | -26.44% | 14.40% |
Frequently asked
- Which has the lower trailing P/E, OMCL or PAHC?
- PAHC has the lower trailing P/E: OMCL trades at 41.64 and PAHC at 15.17. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, OMCL or PAHC?
- Over the past five years, PAHC grew revenue faster — OMCL at a 4.77% CAGR versus PAHC at 12.75%.
- Does OMCL or PAHC pay a bigger dividend?
- PAHC pays a dividend (1.29% yield), while OMCL has no payments in the available dividend history.
- Is OMCL or PAHC more profitable?
- PAHC runs the higher net margin — OMCL at 3.13% versus PAHC at 6.57%.
- How have OMCL and PAHC total returns compared?
- Over the past 10 years, OMCL delivered -0.80% and PAHC delivered 5.27% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Omnicell P/E ratioPhibro Animal Health P/E ratioPhibro Animal Health dividend yieldOmnicell ROEPhibro Animal Health ROEOmnicell operating marginPhibro Animal Health operating marginOmnicell revenue growthPhibro Animal Health revenue growthOmnicell free cash flowPhibro Animal Health free cash flow
Omnicell & Phibro Animal Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.